Grants
Grants funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NSF 25-548: Accelerating Research Translation (ART)
Historical NSF funding solicitation that supported institutions of higher education and eligible U.S. non-profit organizations in building research translation capacity through five tracks covering technology transfer, institutional growth, regional resources, education, and coordination.
NSF 26-1341: Professional Formation of Engineers (PFE)
National Science Foundation's Professional Formation of Engineers (PFE) initiative funds research on how engineers are trained, supported, and integrated into the profession across education and workplace contexts.
PAR-25-270: NCCIH Natural Product Early Phase Clinical Trial Award (R33)
NIH NOFO for R33 early-phase natural-product clinical trials focused on target-engagement evidence before larger efficacy studies, with a direct-cost cap of $1,050,000 over up to 3 years and strict clinical-trial-only eligibility.
RFA-AI-27-012: Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)
NIH/NIAID’s RFA-AI-27-012 established a closed, one-time Coccidioidomycosis Collaborative Research Centers competition focused on Valley fever vaccine research, with 3-4 P01 awards intended for FY 2027.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
The National Cancer Institute's RFA-CA-27-021 supports continued operations and improvement of existing, widely adopted informatics tools and resources for cancer research, with awards capped at $600,000 in direct costs per year for up to five years.
RFA-DC-25-003: Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01, Clinical Trial Required)
NIH/NIDCD funding for investigator-initiated high-risk clinical trials that develop in vivo high-resolution structural and functional imaging technologies for the living human inner ear and support translation into clinical care.
RFA-DC-25-005: In Vivo High-Resolution Imaging for Inner Ear Visualization (R01, Clinical Trial Optional)
This NIH NIDCD R01 NOFO supports higher-resolution structural or functional imaging for the living human inner ear, including eligible low-risk clinical trials, with a per-grant direct-cost limit and a five-year maximum project period.
RFA-DC-26-001: Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
NIH's NIDCD reissue supports early-stage dissemination and implementation (D&I) research that prepares evidence-based communication-disorder interventions for real-world use through a two-year, R21-format mechanism. The next listed application deadline is June 17, 2027.
RFA-FD-25-007: Laboratory Flexible Funding Model (LFFM)
FDA's Laboratory Flexible Funding Model Cooperative Agreement supports state and public laboratories to expand food safety and food defense testing capacity through structured analytical tracks in microbiology, chemistry, and radiochemistry.
RFA-FD-25-020: Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
FDA’s Office of Orphan Products Development supports clinical trials for rare disease products through OOPD RFA-FD-25-020, including recurring 2026 and 2027 due dates with up to $650,000 annually in base project support.